A nationwide shortage of BCG vaccines is leaving Kenyan newborns vulnerable to TB, a disease with high prevalence, health ...

[JONAH ONYANGO/STANDARD.] A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines in the country leaves Kenyan newborns vulnerable to Tuberculosis (TB), a disease with a high prevalence ...

Health Non-Governmental Organisations Network (HENNET) has blamed low budgetary allocation for the recurring vaccine ...

With only seven members, iGEM Eindhoven forms a small but determined student team that aims to help shape the future of ...

JNJ's regulatory filing seeks the FDA's approval for TAR-200, a drug-device combination for treating certain bladder cancer ...

An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin (BCG) immunotherapy, a vaccine also used ...

Indeed, the BCG vaccine was invented whether the leprosy world asked for it or not; and it has not been necessary to consider the need for neonatal BCG vaccination to prevent leprosy, or to ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...